Last reviewed · How we verify
Systane Balance
Systane Balance is a Lubricant eye drops Small molecule drug developed by Southern California College of Optometry at Marshall B. Ketchum University. It is currently FDA-approved. Also known as: Propylene glycol 0.6%.
Systane Balance is a lubricant eye drop that helps to relieve dryness and discomfort by replenishing the tear film.
Systane Balance is a small molecule modality. It is used in a pilot study to investigate its role in regulating bone homeostasis in orthopaedic polytrauma patients.
At a glance
| Generic name | Systane Balance |
|---|---|
| Also known as | Propylene glycol 0.6% |
| Sponsor | Southern California College of Optometry at Marshall B. Ketchum University |
| Drug class | Lubricant eye drops |
| Target | Tear film stability |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
The product contains a combination of lubricating agents that work together to stabilize and enhance the tear film, thereby reducing symptoms of dry eye.
Approved indications
Common side effects
- Eye irritation
- Blurred vision
Key clinical trials
- A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma (PHASE2)
- Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process (NA)
- Comparison of Ocular Lubricants in People With Symptoms of Dry Eye (PHASE4)
- Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp (NA)
- Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma (EARLY_PHASE1)
- Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea (PHASE2)
- Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention (PHASE2)
- A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Systane Balance CI brief — competitive landscape report
- Systane Balance updates RSS · CI watch RSS
- Southern California College of Optometry at Marshall B. Ketchum University portfolio CI
Frequently asked questions about Systane Balance
What is Systane Balance?
How does Systane Balance work?
Who makes Systane Balance?
Is Systane Balance also known as anything else?
What drug class is Systane Balance in?
What development phase is Systane Balance in?
What are the side effects of Systane Balance?
What does Systane Balance target?
Related
- Drug class: All Lubricant eye drops drugs
- Target: All drugs targeting Tear film stability
- Manufacturer: Southern California College of Optometry at Marshall B. Ketchum University — full pipeline
- Therapeutic area: All drugs in Ophthalmology
- Also known as: Propylene glycol 0.6%
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing